347 related articles for article (PubMed ID: 29714053)
1. Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease.
Lee S; Choi BR; Kim J; LaFerla FM; Park JHY; Han JS; Lee KW; Kim J
Mol Nutr Food Res; 2018 Jun; 62(12):e1800240. PubMed ID: 29714053
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice.
Hou TT; Yang HY; Wang W; Wu QQ; Tian YR; Jia JP
J Alzheimers Dis; 2018; 62(4):1803-1813. PubMed ID: 29614663
[TBL] [Abstract][Full Text] [Related]
3. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
Kim J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
[TBL] [Abstract][Full Text] [Related]
4. Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology.
Oddo S; Caccamo A; Tseng B; Cheng D; Vasilevko V; Cribbs DH; LaFerla FM
J Neurosci; 2008 Nov; 28(47):12163-75. PubMed ID: 19020010
[TBL] [Abstract][Full Text] [Related]
5. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
6. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
7. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
8. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
9. Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.
Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Hernandez C; Barrett AD; Dineley K; Kayed R
J Neurosci; 2015 Mar; 35(12):4857-68. PubMed ID: 25810517
[TBL] [Abstract][Full Text] [Related]
10. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
11. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice.
Rodríguez-Navarro JA; Gómez A; Rodal I; Perucho J; Martinez A; Furió V; Ampuero I; Casarejos MJ; Solano RM; de Yébenes JG; Mena MA
Hum Mol Genet; 2008 Oct; 17(20):3128-43. PubMed ID: 18640988
[TBL] [Abstract][Full Text] [Related]
12. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
13. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
14. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB
Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883
[TBL] [Abstract][Full Text] [Related]
15. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid β deposits and peroxidation in mice with Alzheimer-like lesions.
Zhang R; Miao QW; Zhu CX; Zhao Y; Liu L; Yang J; An L
Am J Alzheimers Dis Other Demen; 2015 Mar; 30(2):183-91. PubMed ID: 25024455
[TBL] [Abstract][Full Text] [Related]
18. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
Nies SH; Takahashi H; Herber CS; Huttner A; Chase A; Strittmatter SM
J Biol Chem; 2021 Oct; 297(4):101159. PubMed ID: 34480901
[TBL] [Abstract][Full Text] [Related]
19. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease.
Rothman SM; Herdener N; Frankola KA; Mughal MR; Mattson MP
Brain Res; 2013 Sep; 1529():200-8. PubMed ID: 23856323
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Ali SF; Hanig J; Sarkar S
Curr Alzheimer Res; 2019; 16(5):388-395. PubMed ID: 30907317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
